Literature DB >> 8647683

Radiotherapy for early vocal cord cancer: a dosimetric analysis of 60CO versus 6 MV photons.

M D Sombeck1, K J Kalbaugh, W M Mendenhall, J T Parsons, S A Smith, R R Million, J R Palta.   

Abstract

BACKGROUND: Currently, many patients with early vocal cord cancers are treated with 6 MV photons, but almost all the published radiotherapy data are based on patients treated with 60Co, 2-MV, or 4-MV X-rays. A theoretical risk of underdosage exists with higher energy beams due to lack of dose build-up. This dosimetric study compares 6-MV photons with 60Co.
METHODS: A tissue-equivalent phantom was constructed of a stack of 0.5-cm-thick acrylic plates. With a male subject in treatment position as the model, the external surfaces of the phantom were machined to match the contour of the neck. To precisely represent the internal contour of the airway, computed tomography (CT) was performed on the subject in treatment position, with images at 0.5-cm intervals, and the airway shown on the CT was cut out of each corresponding acrylic plate. Thermoluminescent dosimetry (TLD) rods were inserted into the phantom. For each measurement, a calculated tumor dose of 10 Gy was delivered to the volume specified as the entire right true vocal cord in the phantom, with either 60Co or 6-MV photons (15 measurements were made with each). In a second series of eight experiments with each modality, TLD minichips were used to measure the dose received by the immediate surface of the vocal cords with delivery of a calculated tumor dose of 0.5 Gy.
RESULTS: The doses received at the vocal cords, as well as a point 6 mm beneath the anterior skin surface, did not differ significantly for the two energies compared. The dose delivered to the skin and a point 3 mm beneath the anterior skin surface was significantly lower with the use of 6-MV photons.
CONCLUSION: Although there is no difference in the dose received by the vocal cords, underdosage of the anterior tissues may occur with the use of 6-MV photons.

Entities:  

Mesh:

Year:  1996        PMID: 8647683     DOI: 10.1002/(SICI)1097-0347(199603/04)18:2<167::AID-HED9>3.0.CO;2-#

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  4 in total

1.  Prognostic factors for local control in patients receiving radiation therapy for early glottic cancer: anterior commissure involvement and effect of chemoradiotherapy.

Authors:  Yosuke Kitani; Akira Kubota; Madoka Furukawa; Kaname Sato
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-03-01       Impact factor: 2.503

2.  Impact and relationship of anterior commissure and time-dose factor on the local control of T1N0 glottic cancer treated by 6 MV photons.

Authors:  Chi-Chung Tong; Kwok-Hung Au; Roger K C Ngan; Sin-Ming Chow; Foon-Yiu Cheung; Yiu-Tung Fu; Joseph S K Au; Stephen C K Law
Journal:  Radiat Oncol       Date:  2011-05-21       Impact factor: 3.481

3.  Analysis of prognostic factors for Tis-2N0M0 early glottic cancer with different treatment methods.

Authors:  Guanyu Wang; Guodong Li; Jianjun Wu; Penghui Song
Journal:  Braz J Otorhinolaryngol       Date:  2020-08-06

4.  Treatment of T1b glottic SCC: laser vs. radiation--a Canadian multicenter study.

Authors:  S Mark Taylor; Paul Kerr; Kevin Fung; Mankavil K Aneeshkumar; Derek Wilke; Yida Jiang; John Scott; Judith Phillips; Robert D Hart; Jonathan R B Trites; Matthew H Rigby
Journal:  J Otolaryngol Head Neck Surg       Date:  2013-03-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.